Health Care & Life Sciences » Pharmaceuticals | Jianmin Pharmaceutical Groups Corp. Ltd.

Jianmin Pharmaceutical Groups Corp. Ltd. A | Mutual Funds

Mutual Funds that own Jianmin Pharmaceutical Groups Corp. Ltd. A

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
LC New Blue Chip Balanced Fund
2,923,114
1.91%
-90,400
1.38%
12/31/2017
LC New Trend Equity Fund
2,284,691
1.49%
-170,700
1.57%
12/31/2017
2,164,299
1.41%
0
2.64%
12/31/2017
1,100,000
0.72%
1,100,000
0.68%
12/31/2017
720,000
0.47%
720,000
1.83%
12/31/2017
Fund Kerui
540,458
0.35%
540,458
0.42%
12/31/2016
405,766
0.27%
-1,092,300
0.74%
12/31/2017
300,000
0.2%
-133,912
1.12%
12/31/2017
UBS SDIC Active Innovation Equity Fund
249,001
0.16%
249,001
0.56%
12/31/2017
220,000
0.14%
220,000
2.58%
12/31/2017

About Jianmin Pharmaceutical Groups Corp.

View Profile
Address
No. 484 Yingwu Avenue
Wuhan Hubei 430052
China
Employees -
Website http://www.whjm.com
Updated 07/08/2019
Jianmin Pharmaceutical Group Co., Ltd. engages in the drug research and development, manufacturing, wholesale, and retail business, Its business is divided into pharmaceutical industry and pharmaceutical business sector. The pharmaceutical industry sector carries out drug research and development, manufacturing, and operation; its product focuses on pediatric, gynecology, and old age treatment; the medicine includes granules, tablets, pills, capsules, syrups, and ointments. The pharmaceutical business sector involves in wholesale and retail of pharmaceuticals; its products include traditional Chinese medicine, western medicine, health care products, medical equipment, glass equipment, and chemical agents, The company was founded on June 1, 1953 and is headquartered in Wuhan, China.